Table 3.

Clinicopathological characteristics about the MSI status of CRC

			MSS	MSI-L	MSI-H	P
		n	38 (33%)	23 (20%)	54 (47%)	115
Gender	M	n	25	14	33	088
		%	66	61	61
	F	n	13	9	21
		%	34	39	39
Age	< 50	n	17	7	29	0.169
		%	45	30	54
	< 50	n	21	16	25
		%	55	70	46
	R	n	16	15	42	0.002*
		%	42	65	78
L	L	n	22	8	12
		%	58	35	22
LVE	A	n	30	16	31	0.092
		%	79	70	57
	P	n	8	7	23
		%	21	30	43
PNI	A	n	34	23	48	0.253
		%	90	100	99
	P	n	4	0	6
		%	10	0	11
G	G2	n	30	19	30	0.016*
		%	79	83	56
	G3	n	8	4	24
		%	21	17	44
T	T2	n	6	3	11	0.324
		%	16	13	21
	T3	n	31	20	38
		%	81	87	70
	T4	n	1	0	5
		%	3	0	9
N	N0	n	20	17	35	0.001*
		%	53	74	65
	N1	n	5	6	15
		%	13	26	28
	N2	n	13	0	4
		%	34	0	7
V	NOS	n	31	19	33	0.146
		%	81	83	61
	MUC	n	6	3	19
		%	16	13	35
	Signet	n	1	1	2
		%	3	4	4

G: Gender; L: Laterality; LVE: Lymphovascular Emboli; PNI: perineural Invasion; T: T stage; N: Nodal stage; V: Histopathologic variant; NOS: Non otherwise specified; and MUC: Mucinous.